CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1

CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1

Yunfei Liu, 1 Li Xia, 2 Luo Dong, 1 Jiale Wang, 1 Qiangsheng Xiao, 1 Xiao Yu, 1 Hongwei Zhu 3 1Department of Hepatobiliary and Pancreatic Surgery‖, Third Xiangya Hospital, Central South University, Changsha 410006, People’s Republic of China; 2Department of Endocrinology, Third Xiangya H...

Full description

Bibliographic Details
Main Authors:	Liu Y, Xia L, Dong L, Wang J, Xiao Q, Yu X, Zhu H
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-02-01
Series:	Cancer Management and Research
Subjects:	pancreatic cancer circular rna gemcitabine resistance biomarker
Online Access:	https://www.dovepress.com/circhipk3-promote-gemcitabine-gem-resistance-in-pancreatic-cancer-cell-peer-reviewed-article-CMAR

Similar Items

Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF
by: Liu Y, et al.
Published: (2019-10-01)

CircHIPK3 Promotes Pyroptosis in Acinar Cells Through Regulation of the miR-193a-5p/GSDMD Axis
by: Jiale Wang, et al.
Published: (2020-04-01)

CircHIPK3 Plays Vital Roles in Cardiovascular Disease
by: Lei Zhang, et al.
Published: (2021-09-01)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
by: Feng Shao, et al.
Published: (2018-06-01)

Circular RNA circHIPK3 Promotes the Proliferation and Differentiation of Chicken Myoblast Cells by Sponging miR-30a-3p
by: Biao Chen, et al.
Published: (2019-02-01)

Imexon and Gemcitabine: Mechanisms of Synergy against Human Pancreatic Cancer
by: Roman, Nicholas
Published: (2005)

CircHIPK3 Promotes the Tumorigenesis and Development of Gastric Cancer Through miR-637/AKT1 Pathway
by: Dejun Yang, et al.
Published: (2021-02-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Epibrassinolide Promotes the Apoptotic Potential of Gemcitabine in Pancreatic Cancer Cells
by: Fadina Kuryayeva, et al.
Published: (2019-12-01)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)

Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
by: Salma Alam, et al.
Published: (2018-04-01)

Review of molecular mechanisms underlying gemcitabine resistance in pancreatic cancer
by: A. Rajabpour, et al.
Published: (2017-10-01)

Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression
by: Chen D, et al.
Published: (2019-02-01)

Clinically Meaningful Responses to Sequential Gemcitabine-Based Chemotherapy Regimens in a Patient with Metastatic Pancreatic Cancer
by: Eiko Klimant, et al.
Published: (2013-01-01)

Circular RNA CircHIPK3 Elevates CCND2 Expression and Promotes Cell Proliferation and Invasion Through miR-124 in Glioma
by: Zengjin Liu, et al.
Published: (2020-08-01)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01)

Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression
by: Weidong Shi, et al.
Published: (2019-02-01)

circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637Research in context
by: Yanli Zhang, et al.
Published: (2019-10-01)

circHIPK3 Promotes Cell Proliferation and Migration of Gastric Cancer by Sponging miR-107 and Regulating BDNF Expression
by: Wei J, et al.
Published: (2020-02-01)

CircHIPK3 Facilitates the G2/M Transition in Prostate Cancer Cells by Sponging miR-338-3p
by: Liu F, et al.
Published: (2020-05-01)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
by: Lei You, et al.
Published: (2018-12-01)

Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)

Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors
by: Priyanka Swami, et al.
Published: (2021-04-01)

Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
by: Manoj Amrutkar, et al.
Published: (2019-06-01)

Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p
by: Xu X, et al.
Published: (2020-12-01)

The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance
by: Omar Elaskalani, et al.
Published: (2017-10-01)

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine
by: Zhengdong Jiang, et al.
Published: (2016-09-01)

Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone
by: Hua Chen, et al.
Published: (2018-10-01)

Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
by: Wu LW, et al.
Published: (2019-06-01)

The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
by: Jalal Baig, et al.
Published: (2019-07-01)

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma
by: Eiichiro So, et al.
Published: (2017-08-01)

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
by: Gong DJ, et al.
Published: (2013-07-01)

A [60]fullerene nanoconjugate with gemcitabine: synthesis, biophysical properties and biological evaluation for treating pancreatic cancer
by: Paweł Nalepa, et al.
Published: (2020-02-01)

Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
by: Manoj Amrutkar, et al.
Published: (2021-02-01)

Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC
by: HB Jin, et al.
Published: (2019-05-01)

Biogenesis, cellular effects, and biomarker value of circHIPK3
by: Yihan Fu, et al.
Published: (2021-05-01)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
by: Amber Blaauboer, et al.
Published: (2020-09-01)

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
by: Waisse Waissi, et al.
Published: (2021-06-01)

Predictive Values of Blood-Based RNA Signatures for the Gemcitabine Response in Advanced Pancreatic Cancer
by: David Piquemal, et al.
Published: (2020-10-01)

Circular RNA CircHIPK3 Promotes NCI-H1299 and NCI-H2170 Cell Proliferation through miR-379 and its Target IGF1
by: Fang TIAN, et al.
Published: (2017-06-01)